Skip to main content

Former Biogen exec wants new RTP startup to be an asset for Big Pharma

A Triangle startup led by a former Biogen executive is raising capital to advance its lead drug into clinical trials.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.